These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16036046)

  • 1. Disruptions and detours in the myocardial matrix highway and heart failure.
    Deschamps AM; Spinale FG
    Curr Heart Fail Rep; 2005 Mar; 2(1):10-7. PubMed ID: 16036046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular degradative pathways in myocardial remodeling and progression to heart failure.
    Spinale FG; Gunasinghe H; Sprunger PD; Baskin JM; Bradham WC
    J Card Fail; 2002 Dec; 8(6 Suppl):S332-8. PubMed ID: 12555141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix modulation and heart failure: new concepts question old beliefs.
    Deschamps AM; Spinale FG
    Curr Opin Cardiol; 2005 May; 20(3):211-6. PubMed ID: 15861009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial remodelling and matrix metalloproteinases in heart failure: turmoil within the interstitium.
    Wilson EM; Spinale FG
    Ann Med; 2001 Dec; 33(9):623-34. PubMed ID: 11817657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Myocardial Extracellular Matrix Dynamic Changes in Myocardial Infarction and Postinfarct Remodeling.
    Ushakov A; Ivanchenko V; Gagarina A
    Curr Cardiol Rev; 2020; 16(1):11-24. PubMed ID: 31072294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the myocardial interstitium and contribution to the progression of heart failure.
    Eckhouse SR; Spinale FG
    Heart Fail Clin; 2012 Jan; 8(1):7-20. PubMed ID: 22108723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblasts and the extracellular matrix in right ventricular disease.
    Frangogiannis NG
    Cardiovasc Res; 2017 Oct; 113(12):1453-1464. PubMed ID: 28957531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
    Spinale FG
    Physiol Rev; 2007 Oct; 87(4):1285-342. PubMed ID: 17928585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.
    Li YY; McTiernan CF; Feldman AM
    Cardiovasc Res; 2000 May; 46(2):214-24. PubMed ID: 10773225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metallopropteinases in heart failure.
    Tousoulis D; Kampoli AM; Papageorgiou N; Antoniades C; Siasos G; Latsios G; Tsiamis E; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1181-91. PubMed ID: 22519448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix matters.
    Libby P; Lee RT
    Circulation; 2000 Oct; 102(16):1874-6. PubMed ID: 11034930
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrins, membrane-type matrix metalloproteinases and ADAMs: potential implications for cardiac remodeling.
    Manso AM; Elsherif L; Kang SM; Ross RS
    Cardiovasc Res; 2006 Feb; 69(3):574-84. PubMed ID: 16253214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix remodeling following myocardial injury.
    Lindsey ML; Mann DL; Entman ML; Spinale FG
    Ann Med; 2003; 35(5):316-26. PubMed ID: 12952018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target.
    Spinale FG; Coker ML; Bond BR; Zellner JL
    Cardiovasc Res; 2000 May; 46(2):225-38. PubMed ID: 10773226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular matrix remodeling during the progression of volume overload-induced heart failure.
    Hutchinson KR; Stewart JA; Lucchesi PA
    J Mol Cell Cardiol; 2010 Mar; 48(3):564-9. PubMed ID: 19524591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy].
    Pauschinger M; Chandrasekharan K; Li J; Schwimmbeck PL; Noutsias M; Schultheiss HP
    Herz; 2002 Nov; 27(7):677-82. PubMed ID: 12439639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac remodeling and failure From molecules to man (Part II).
    Fedak PW; Verma S; Weisel RD; Li RK
    Cardiovasc Pathol; 2005; 14(2):49-60. PubMed ID: 15780796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling myocardial matrix remodeling: implications for heart failure.
    Rao VU; Spinale FG
    Cardiol Rev; 1999; 7(3):136-43. PubMed ID: 10423664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases: regulation and dysregulation in the failing heart.
    Spinale FG
    Circ Res; 2002 Mar; 90(5):520-30. PubMed ID: 11909815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.